TET3 and clear cell adenocarcinoma: Comparing with borderline tumors and normal tissues, TET3 mRNA was significantly up-regulated in ovarian cancer (Fig. 1f), including serous adenocarcinoma (P < 0.0001, logFC = 0.811), endometrioid adenocarcinoma (P < 0.0001, logFC = 0.8794), clear cell adenocarcinoma (P < 0.0001, logFC = 1.004) and mucinous adenocarcinoma (P = 0.0003, logFC = 0.7978).